-
Mashup Score: 18MOC®: It's All About Physician Data - 1 day(s) ago
The Facebook–Cambridge Analytica data scandal was a major political scandal in early 2018 when it was revealed that Cambridge Analytica had …
Source: drwes.blogspot.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 570
Viscoelastic testing (VET), including thromboelastography and thromboelastometry, provides a rapid and comprehensive picture of whole blood coagulation dynamics and hemostasis that can be reviewed and evaluated at the point-of-care. This technology is over 50 years old; however, over the past few years, there has been a significant increase in research examining the use of VET. Best practice guidelines for the use of VET exist in both the United States and Europe, particularly for elective cardiac surgery, although recommendations for implementation are somewhat limited in some clinical areas by the lack of studies constituting high-grade evidence.
Source: www.rpthjournal.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Chasing Kurt Cobain in Washington State (Published 2014) - 16 day(s) ago
Almost 20 years after the rock legend’s death, visiting spots where he lived, and where he endures today.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10Sign the Petition - 17 day(s) ago
Eliminate ABIMs MOC requirement
Source: www.change.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 101Sign the Petition - 18 day(s) ago
Eliminate ABIMs MOC requirement
Source: www.change.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 59
AbstractPurpose:. Differentiation syndrome (DS) is a serious adverse reaction of isocitrate dehydrogenase (IDH) inhibitors ivosidenib and enasidenib in patients with (IDH)1- and IDH2-mutated acute myeloid leukemia (AML), respectively.Experimental Design:. During FDA review of marketing applications for ivosidenib and enasidenib, data from pivotal trials were queried to identify cases of DS in patients with relapsed or refractory (R/R) AML. One hundred seventy-nine patients with R/R AML received ivosidenib and 214 received enasidenib. Adverse events, labs, and vital signs in the first 90 days of treatment were screened per diagnostic criteria, and narratives were reviewed to adjudicate DS cases.Results:. We identified 72 of 179 (40%) potential cases for ivosidenib and 86 of 214 (40%) for enasidenib; 34 of 179 (19%) and 41 of 214 (19%) were adjudicated as DS. Leukocytosis was present in 79% and 61% of cases, respectively. Median (range) time to onset was 20 (1–78) and 19 (1–86) days. Gra
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18Pearl Jam Announces New Album and 2024 World Tour as Eddie Vedder Declares Band Has Made Its 'Best Work' - 23 day(s) ago
Pearl Jam will release its 12th album ‘Dark Matter’ in April, before a world tour kicks off the following month. Eddie Vedder describes the new album as the band’s “best work.”
Source: PEOPLE.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 101Sign the Petition - 24 day(s) ago
Eliminate ABIMs MOC requirement
Source: www.change.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 40Opinion | Let's Fix Maintenance of Certification - 28 day(s) ago
It’s time to simplify the process, reduce costs, and eliminate redundancies
Source: www.medpagetoday.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 83Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval - 29 day(s) ago
This study aims to determine whether cancer drugs granted accelerated approval from the US Food and Drug Administration ultimately demonstrate clinical benefit and to evaluate the basis of conversion to regular approval.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
Read @doctorwes article on why the ABIM pushes MOC. Then sign the petition to end it. Article: https://t.co/OP4K8fMUrj Petition: https://t.co/DaY8yRBp7R